Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs

Antiviral Research

Volumn 108, Issue 1, 2014, Pages 165-172

  Busquets, Núria ^a   Lorenzo, Gema ^b   López Gil, Elena ^b   Rivas, Raquel ^a   Solanes, David ^a   Galindo Cardiel, Iván ^c,d   Abad, F Xavier ^a   Rodríguez, Fernando ^a   Bensaid, Albert ^a   Warimwe, George ^e   Gilbert, Sarah C ^e   Domingo, Mariano ^a,c   Brun, Alejandro ^b  

^a CENTRE DE RECERCA EN SANITAT ANIMAL CRESA   (Spain)

^b Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d WorldPathol SL   (Spain)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

GnGc glycoproteins; MVA vaccine; Rift Valley Fever virus; Sheep experimental infection; Virus shedding

Indexed keywords

RECOMBINANT VACCINE; RMVA GNGC VACCINE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS RNA; VIRUS VACCINE; DRUG CARRIER;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEVER; IMMUNITY; IMMUNIZATION; LAMB; LIVER INJURY; MALE; NONHUMAN; NOSE SMEAR; ORAL BIOPSY; PRIORITY JOURNAL; RIFT VALLEY FEVER; RIFT VALLEY FEVER BUNYAVIRUS; SEROCONVERSION; SURVIVOR; VECTOR CONTROL; VIRUS SHEDDING; VIRUS STRAIN; VIRUS TITRATION; ANIMAL; GENE VECTOR; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER; MOUTH; NOSE CAVITY; PATHOLOGY; RIFT VALLEY FEVER VIRUS; SHEEP; SHEEP DISEASES; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL; TREATMENT OUTCOME; VACCINIA VIRUS; VIROLOGY;

ANIMALS; DRUG CARRIERS; FEMALE; FEVER; GENETIC VECTORS; INJECTIONS, SUBCUTANEOUS; LIVER; MALE; MOUTH; NASAL CAVITY; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; RNA, VIRAL; SHEEP; SHEEP DISEASES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VACCINES, SYNTHETIC; VACCINIA VIRUS; VIRAL VACCINES; VIRUS SHEDDING;

EID: 84903741957     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.05.020     Document Type: Article

References (31)

1. F. Amraoui, G. Krida, A. Bouattour, A. Rhim, J. Daaboub, Z. Harrat, S.C. Boubidi, M. Tijane, M. Sarih, and A.B. Failloux Culex pipiens, an experimental efficient vector of west Nile and Rift Valley fever viruses in the Maghreb region PLoS One 7 2012 e36757
2. A.F. Antonis, R.G. van der Most, Y. Suezer, N. Stockhofe-Zurwieden, F. Daus, G. Sutter, and R.S. Schrijver Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge Vaccine 25 2007 4818 4827 (Pubitemid 46818613)
3. H.H. Balkhy, and Z.A. Memish Rift Valley fever: an uninvited zoonosis in the Arabian peninsula Int. J. Antimicrob. Agents 21 2003 153 157 (Pubitemid 36300792)
4. B.J. Barnard, and M.J. Botha An inactivated rift valley fever vaccine J. S. Afr. Vet. Assoc. 48 1977 45 48
5. B.H. Bird, and S.T. Nichol Breaking the chain: Rift Valley fever virus control via livestock vaccination Curr. Opin. Virol. 2 2012 315 323
6. M. Bouloy, and F. Weber Molecular biology of rift valley fever virus Open Virol. J. 4 2010 8 14
7. C.C. Breathnach, H.J. Clark, R.C. Clark, C.W. Olsen, H.G. Townsend, and D.P. Lunn Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge Vaccine 24 2006 1180 1190 (Pubitemid 43202264)
8. N. Busquets, F. Xavier, R. Martin-Folgar, G. Lorenzo, I. Galindo-Cardiel, B.P. del Val, R. Rivas, J. Iglesias, F. Rodriguez, D. Solanes, M. Domingo, and A. Brun Experimental infection of young adult European breed sheep with Rift Valley fever virus field isolates Vector Borne Zoonotic Dis. 10 2010 689 696
9. R. Chiam, E. Sharp, S. Maan, S. Rao, P. Mertens, B. Blacklaws, N. Davis-Poynter, J. Wood, and J. Castillo-Olivares Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA) PLoS One 4 2009 e5997
10. B. Dungu, I. Louw, A. Lubisi, P. Hunter, B.F. von Teichman, and M. Bouloy Evaluation of the efficacy and safety of the Rift Valley fever Clone 13 vaccine in sheep Vaccine 28 2010 4581 4587
11. G.H. Gerdes Rift Valley fever Rev. Sci. Technol. 23 2004 613 623 (Pubitemid 40180988)
12. S.R. Gerrard, and S.T. Nichol Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins Virology 357 2007 124 133 (Pubitemid 44821298)
13. R. Gorchakov, E. Volkova, N. Yun, O. Petrakova, N.S. Linde, S. Paessler, E. Frolova, and I. Frolov Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins Virology 366 2007 212 225 (Pubitemid 47314401)
14. D.G. Harrington, H.W. Lupton, C.L. Crabbs, C.J. Peters, J.A. Reynolds, and T.W. Slone Jr. Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep Am. J. Vet. Res. 41 1980 1559 1564
15. M.T. Heise, A. Whitmore, J. Thompson, M. Parsons, A.A. Grobbelaar, A. Kemp, J.T. Paweska, K. Madric, L.J. White, R. Swanepoel, and F.J. Burt An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus Epidemiol. Infect. 137 2009 1309 1318
16. D.H. Holman, A. Penn-Nicholson, D. Wang, J. Woraratanadharm, M.K. Harr, M. Luo, E.M. Maher, M.R. Holbrook, and J.Y. Dong A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity Clin. Vaccine Immunol. 16 2009 1624 1632
17. J. Kortekaas, A. Dekker, S.M. de Boer, K. Weerdmeester, R.P. Vloet, A.A. de Wit, B.P. Peeters, and R.J. Moormann Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus Vaccine 28 2010 2271 2276
18. J. Kortekaas, J. Zingeser, P. de Leeuw, S. de La Rocque, H. Unger, and R.J. Moormann Rift valley Fever vaccine development, progress and constraints Emerg. Infect. Dis. 17 2011 e1
19. E. Lopez-Gil, G. Lorenzo, E. Hevia, B. Borrego, M. Eiden, M. Groschup, S.C. Gilbert, and A. Brun A Single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a Lethal RVFV infection PLoS Negl. Trop. Dis. 7 2013 e2309
20. J.C. Morrill, R.C. Laughlin, N. Lokugamage, R. Pugh, E. Sbrana, W.J. Weise, L.G. Adams, S. Makino, and C.J. Peters Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep Vaccine 31 2013 559 565
21. J.C. Morrill, R.C. Laughlin, N. Lokugamage, J. Wu, R. Pugh, P. Kanani, L.G. Adams, S. Makino, and C.J. Peters Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves Vaccine 31 2013 4988 4994
22. R. Muller, J.F. Saluzzo, N. Lopez, T. Dreier, M. Turell, J. Smith, and M. Bouloy Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment Am. J. Trop. Med. Hyg. 53 1995 405 411
23. N. Oreshkova, L. van Keulen, J. Kant, R.J. Moormann, and J. Kortekaas A single vaccination with an improved nonspreading rift valley fever virus vaccine provides sterile immunity in lambs PLoS One 8 2013 e77461
24. J.F. Papin, P.H. Verardi, L.A. Jones, F. Monge-Navarro, A.C. Brault, M.R. Holbrook, M.N. Worthy, A.N. Freiberg, and T.D. Yilma Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice Proc. Natl. Acad. Sci. U.S.A. 108 2011 14926 14931
25. M. Pepin, M. Bouloy, B.H. Bird, A. Kemp, and J. Paweska Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention Vet. Res. 41 2010 61
26. L.J. Reed, and H. Muench A simple method of estimating 50 percent endpoints Am. J. Epidemiol. 27 1938 493 497
27. D. Sissoko, C. Giry, P. Gabrie, A. Tarantola, F. Pettinelli, L. Collet, E. D'Ortenzio, P. Renault, and V. Pierre Rift Valley fever, Mayotte, 2007-2008 Emerg. Infect. Dis. 15 2009 568 570
28. K.C. Smithburn Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine Br. J. Exp. Pathol. 30 1949 1 16
29. R.K. Soi, F.R. Rurangirwa, T.C. McGuire, P.M. Rwambo, J.C. Demartini, and T.B. Crawford Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine Clin. Vaccine Immunol. 17 2010 1842 1849
30. D.B. Wallace, C.E. Ellis, A. Espach, S.J. Smith, R.R. Greyling, and G.J. Viljoen Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever Vaccine 24 2006 7181 7189 (Pubitemid 46107193)
31. G.M. Warimwe, G. Lorenzo, E. Lopez-Gil, A. Reyes-Sandoval, M.G. Cottingham, A.J. Spencer, K.A. Collins, M. Dicks, A. Milicic, A. Lall, J. Furze, A.V. Turner, A.V. Hill, A. Brun, and S.C. Gilbert Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice Virol. J. 10 2013 349